Navigation Links
NC Biomanufacturers Supply Defense for World vs. Flu

Huge GSK, Novartis, Merck plants help define state's economic successes

RESEARCH TRIANGLE PARK, N.C., April 29 /PRNewswire-USNewswire/ -- The global fight against swine flu is shining a spotlight on North Carolina's long-term commitment to biomanufacturing.

Global pharmaceutical giant GlaxoSmithKline, with North American headquarters in Research Triangle Park, is one of the world's two key manufacturers of antiviral flu treatments. GSK makes Relenza at its plant in Zebulon, about 25 miles east of its headquarters campus.

GSK and Swiss drug company Roche, which makes Tamiflu, have notified the World Health Organization that this new strain of the swine-flu virus seems to respond to their medicines.

"When we're called upon to tackle these kinds of disease outbreaks, North Carolina's excellent base of medical research and pharmaceutical manufacturing puts us among global leaders," said E. Norris Tolson, president and CEO of the North Carolina Biotechnology Center.

North Carolina has invested $1.2 billion in steady bioscience growth during the past decade, said Tolson. "Some states aren't so interested in manufacturing. But at times like these, it becomes clear why these science-driven factories are so crucial."

Hundreds of workers at GSK's Zebulon factory have made medicines to supply the world for more than two decades. Meanwhile, Novartis has a flu-vaccine plant under construction at the edge of Holly Springs, about 20 miles southwest of Raleigh.

Read the full story online.

The Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.

Contact: Chris Brodie, vice president of corporate communications, North Carolina Biotechnology Center, or 919-541-9366. Visit the Biotechnology Center's Web site at

SOURCE North Carolina Biotechnology Center
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hospira Names Brian Meadows Supply Chain Chief
2. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
3. Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform
4. New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel
5. Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
6. SurgiQuest Signs a Development and Supply Agreement with Intuitive Surgical for MIS Access Utilizing the AirSeal(TM) Technology
7. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
8. ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4
9. Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin
10. Wyeth Names Michael Kamarck President, Technical Operations & Product Supply
11. Health Robotics Announces Contract for its CytoCare(TM) and IV Station(TM) Robots With Arabian Health Care Supply Corporation
Post Your Comments:
(Date:11/24/2015)... ... 2015 , ... The United States Golf Association (USGA) today announced Dr. Bruce ... Presented annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service ... , Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... But unless it is bound to proteins, copper is also toxic to cells. ... at Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper in ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
Breaking Biology Technology:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
Breaking Biology News(10 mins):